The Thr92AlaD2 polymorphism may play a novel role in hypothyroidism

Elizabeth A. McAninch, Antonio C. Bianco

Research output: Contribution to journalArticlepeer-review

Abstract

The type 2 deiodinase (D2) has an important role in hypothyroidism, where its ability to activate thyroid hormone provides justification for levothyroxine "monotherapy." A prevalent polymorphism in D2, Thr92AlaD2, has been associated with improved well-being on "combination therapy" with T4+T3; the underlying mechanism is unclear as T4-to-T3 conversion appears normal. Novel studies indicate this might be a risk factor for neurodegenerative disease. If the relationship between Thr92AlaD2-expression and treatment preference is confirmed, personalized medicine may play a role in hypothyroidism.

Original languageEnglish (US)
Pages (from-to)92-94
Number of pages3
JournalUS Endocrinology
Volume11
Issue number2
DOIs
StatePublished - 2015
Externally publishedYes

Keywords

  • Deiodinase
  • Hypothyroidism
  • Levothyroxine
  • Polymorphism

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'The Thr92AlaD2 polymorphism may play a novel role in hypothyroidism'. Together they form a unique fingerprint.

Cite this